Literature DB >> 8929988

Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture.

K Pietz1, P Odin, K Funa, O Lindvall.   

Abstract

The effects of platelet-derived growth factor (PDGF)-AA and -BB on 6-hydroxydopamine (6-OHDA)-induced degeneration of dopaminergic (DA) neurons were studied in cultures of dissociated fetal rat mesencephalon. The 6-OHDA lesion (0.3% for 4 h) caused a selective 75% loss of tyrosine hydroxylase (TH)-positive DA neurons. The neuronal death was significantly decreased (to about 25%) by addition of 1, 10 or 30 (but not 0.1) ng/ml of PDGF-BB 24 h prior to the insult. In contrast, treatment with PDGF-AA (30 ng/ml) for 24 h before the lesion or addition of PDGF-BB (30 ng/ml) simultaneously with or 1 h after 6-OHDA did not promote the survival of TH-positive neurons. We conclude that PDGF-BB can counteract 6-OHDA-induced degeneration of mesencephalic DA neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929988     DOI: 10.1016/0304-3940(96)12326-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1.

Authors:  Fuwang Peng; Honghong Yao; Xuetao Bai; Xuhui Zhu; Benjamin C Reiner; Michael Beazely; Keiko Funa; Huangui Xiong; Shilpa Buch
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients.

Authors:  Gesine Paul; Olof Zachrisson; Andrea Varrone; Per Almqvist; Markus Jerling; Göran Lind; Stig Rehncrona; Bengt Linderoth; Hjalmar Bjartmarz; Lisa L Shafer; Robert Coffey; Mikael Svensson; Katarina Jansson Mercer; Anton Forsberg; Christer Halldin; Per Svenningsson; Håkan Widner; Jonas Frisén; Sven Pålhagen; Anders Haegerstrand
Journal:  J Clin Invest       Date:  2015-02-17       Impact factor: 14.808

3.  Growth factor signaling: implications for disease & therapeutics.

Authors:  Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-09       Impact factor: 4.147

4.  Neuron-specific ablation of PDGF-B is compatible with normal central nervous system development and astroglial response to injury.

Authors:  Maria Enge; Ulrika Wilhelmsson; Alexandra Abramsson; Josefina Stakeberg; Ralf Kühn; Christer Betsholtz; Milos Pekny
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

Review 5.  Current disease modifying approaches to treat Parkinson's disease.

Authors:  Dan Lindholm; Johanna Mäkelä; Valentina Di Liberto; Giuseppa Mudò; Natale Belluardo; Ove Eriksson; Mart Saarma
Journal:  Cell Mol Life Sci       Date:  2015-11-30       Impact factor: 9.261

6.  Mechanisms of platelet-derived growth factor-mediated neuroprotection--implications in HIV dementia.

Authors:  Fuwang Peng; Navneet K Dhillon; Honghong Yao; Xuhui Zhu; Rachel Williams; Shilpa Buch
Journal:  Eur J Neurosci       Date:  2008-10       Impact factor: 3.386

7.  Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.

Authors:  Ji Yong Lee; Hyun Soo Kim; Sung Hoon Kim; Han-Soo Kim; Byung Pil Cho
Journal:  Tissue Eng Regen Med       Date:  2020-01-22       Impact factor: 4.169

8.  Bone marrow stromal cell transdifferentiation into oligodendrocyte-like cells using triiodothyronine as a inducer with expression of platelet-derived growth factor α as a maturity marker.

Authors:  Hojjat-Allah Abbaszadeh; Taki Tiraihi; Ali Reza Delshad; Majid Saghedi Zadeh; Taher Taheri
Journal:  Iran Biomed J       Date:  2013-04

9.  Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.

Authors:  Fuwang Peng; Honghong Yao; Halis Kaan Akturk; Shilpa Buch
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes.

Authors:  Philipp Mahlknecht; Sylvia Stemberger; Markus Reindl; Fabienne Sprenger; Johannes Rainer; Eva Hametner; Rudolf Kirchmair; Christoph Grabmer; Christoph Scherfler; Gregor K Wenning; Klaus Seppi; Werner Poewe
Journal:  Proteome Sci       Date:  2012-11-23       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.